Neogenomics Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 29.47M34.37M43.48M157.59M173.78M224.46M225.06M231.81M240.25M276.74M408.83M444.45M484.33M509.73M591.64M660.57M
Cost of Revenue 14.25M18.59M24.06M33.03M34.73M46.35M56.05M133.70M138.29M149.48M211.99M258.56M297.27M321.83M347.04M370.47M
Gross Profit 15.21M15.78M19.43M26.84M31.74M40.71M43.76M98.10M101.96M127.27M196.84M185.89M187.06M187.90M244.60M290.10M
Operating items
Research & Development 0.54M2.28M2.44M2.69M4.20M4.65M3.64M3.00M8.49M8.23M21.87M30.33M27.31M31.16M
Selling, General & Administrative 10.06M11.27M12.33M15.84M17.40M23.81M33.63M63.93M70.36M84.82M127.99M143.79M221.35M243.36M243.10M259.74M
Restructuring Costs 4.52M11.09M
Other Operating Expenses 6.89M7.48M6.96M7.50M-3.34M-34.08M-71.36M27.37M-1.06M29.40M47.35M47.86M62.59M67.32M70.84M91.31M
Operating Expenses 16.94M18.75M19.84M25.62M28.56M38.50M49.39M95.95M99.05M117.22M183.83M199.88M305.81M345.52M352.34M382.21M
Operating Income -1.73M-2.96M-0.41M1.21M3.17M2.22M-5.63M2.15M2.90M10.04M13.01M-13.99M-118.75M-157.62M-107.74M-92.11M
EBIT -1.73M-2.96M-0.41M1.21M3.17M2.22M-5.63M2.15M2.90M10.04M13.01M-13.99M-118.75M-157.62M-107.74M-92.11M
Non-operating items
Interest & Investment Income 6.08M16.90M18.43M
Other Non Operating Income 0.37M0.06M2.00M-0.01M0.01M-4.63M7.91M-0.50M-0.21M0.64M-0.38M
Non Operating Income -0.52M-0.34M-0.77M-1.15M-0.99M0.06M2.00M-0.01M0.01M-4.63M7.91M-0.50M-0.21M0.64M-0.38M
Net income details
EBT -1.20M-3.67M-1.18M0.07M2.19M1.29M-4.49M-7.84M-2.65M3.82M3.65M-14.06M-15.07M-159.34M-97.10M-80.67M
Tax Provisions 0.15M0.16M-1.95M-1.70M-2.25M1.18M-4.36M-18.23M-6.73M-15.09M-9.13M-1.95M
Profit After Tax -2.24M-3.30M-1.18M0.07M2.03M1.13M-2.54M-6.14M-0.40M2.64M8.01M4.17M-8.35M-144.25M-87.97M-78.73M
Investment Income 0.04M-0.07M
Income from Continuing Operations -1.20M-3.67M-1.18M0.07M2.03M1.13M-2.54M-6.14M-0.40M2.64M8.01M4.17M-8.35M-144.25M-87.97M-78.73M
Consolidated Net Income -1.20M-3.67M-1.18M0.07M2.03M1.13M-2.54M-6.14M-0.40M2.64M8.01M4.17M-8.35M-144.25M-87.97M-78.73M
Income towards Parent Company -1.20M-3.67M-1.18M0.07M2.03M1.13M-2.54M-6.14M-0.40M2.64M8.01M4.17M-8.35M-144.25M-87.97M-78.73M
Preferred Dividend Payments 0.04M18.01M10.55M5.63M
Net Income towards Common Stockholders -1.20M-3.67M-1.18M0.07M2.03M1.13M-2.66M-30.82M-10.94M6.09M8.01M4.17M-8.35M-144.25M-87.97M-78.73M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M0.00M0.00M-0.00M-0.00M-0.00M0.00M0.00M0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 37.18M37.41M43.24M45.28M48.97M59.97M75.86M78.51M80.41M93.02M104.83M111.03M123.12M126.30M127.47M128.36M
Shares Outstanding (Diluted Average) 34.64M77.54M79.43M91.57M103.61M111.79M119.96M124.22M125.50M126.66M
EBITDA -1.73M-2.96M-0.41M1.21M3.17M2.22M-5.63M2.15M2.90M10.04M13.01M-13.99M-118.75M-157.62M-107.74M-92.11M
Tax Rate 6.96%12.18%43.53%21.69%85.06%30.96%44.63%9.47%9.40%2.42%